News Release

< Back

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

February 14, 2024 at 7:50 AM EST
PDF Version 2025-09-22 20:23:08

Contact Info

LakeShore Biopharma, Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +86 (10) 61253627

ir@lakeshorebio.com

Copyright © 2025 Lakeshore Biopharma. All Rights Reserved.